MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Inflammation"

  • 2023 International Congress

    LRRK2 G2019S promotes astrocytic inflammatory response induced by oligomeric α-synuclein through NF-κB pathway

    JY. Liu, KJ. He, JB. Zhang, F. Wang, CF. Liu (Suzhou, China)

    Objective: Analyzing the mechanism of inflammatory response induced by oligomeric α-synuclein (O-αS) in LRRK2 G2019S mutation astrocytes to provide new targets and ideas for the…
  • 2023 International Congress

    Associations of IL-1β and IL-6 gene polymorphisms with Parkinson’s disease(PD)

    M. Ben Mahmoud, S. Fray, H. Jamoussi, N. Ben Ali, M. Fredj, S. Fezai (Tunis)

    Objective: We aim to explore the associations of IL-1β and IL-6 gene polymorphisms with the pathogenesis of PD and with clinical features of motor and…
  • 2023 International Congress

    Honey prevented MPTP-induced oxidative stress, neuroinflammation and gliosis in adult male Swiss mice.

    F. Sulaimon, R. Ibiyeye, A. Imam, A. Imam, M. Ajao (Ilorin, Nigeria)

    Objective: To investigate the neuroprotective role of honey against oxidative stress and neuroinflammation induced by MPTP in adult male Swiss mice. Background: Oxidative stress and…
  • 2022 International Congress

    Inflammatory biomarkers in newly diagnosed patients with Parkinson’s disease

    C. Pedersen, A. Ushakova, G. Alves, O-B. Tysnes, D. Aarsland, J. Lange, J. Maple-Grødem (Sandnes, Norway)

    Objective: To identify a panel of cerebrospinal fluid (CSF) inflammatory biomarkers for Parkinson’s disease (PD) and to compare levels of inflammatory proteins in control subjects…
  • 2022 International Congress

    SCFAs participate in the pathogenesis of Parkinson’s disease by regulating NLRP3 inflammasomes activation

    Z. Mao, J. Xiong, Z. Min, Z. Xue (Wuhan, China)

    Objective: To explore the role and related mechanism of gut microbiota metabolites short-chain fatty acids(SCFAs) in the pathogenesis of Parkinson's disease(PD). Background: Growing research have…
  • 2022 International Congress

    Multi-modal prognostic biomarkers for Parkinson’s disease progression and severity

    AS. Rolland, M. Dutheil, O. Simonin, R. Viard, V. Huin, M. Kyheng, C. Moreau, S. Thobois, A. Eusebio, E. Hainque, I. Benatru, D. Maltete, C. Giordana, M. Tir, C. Hubsch, B. Jarraya, F. Durif, C. Brefel-Courbon, O. Rascol, JC. Corvol, G. Garçon, D. Devos (Lille, France)

    Objective: To determine a pathophysiological panel of biomarkers significantly associated with the severity and the disease progression of Parkinson’s disease. Background: Detecting, monitoring and predicting…
  • 2022 International Congress

    Dried blood and plasma spots for the measurement of neurofilament light chain and inflammatory cytokines in patients with REM sleep behaviour disorder

    B. Huxford, C. Simonet, L. Carbonell, A. Zirra, N. Vickaryous, A. Gill, A. Schrag, R. Dobson, A. Noyce (London, United Kingdom)

    Objective: The objective of this study was to investigate the relationship between plasma and dried blood/ plasma spot measurements of inflammatory markers (IFN-ɣ, IL-1β, IL-6,…
  • 2022 International Congress

    Genetic correlation and potential causal relationship between inflammatory bowel disease and Parkinson’s disease

    S. Grover, E. Wacker, A. Kumar-Sreelatha, A. Elbaz, R. Krüger, T. Gasser, D. Ellinghaus, M. Sharma (Tuebingen, Germany)

    Objective: The present study investigates shared genetic etiology between inflammatory bowel disease (IBD) and Parkinson’s disease (PD) using correlation and causality-based approaches. Background: The role…
  • 2022 International Congress

    Beneficial effects of cinnamaldehyde in orofacial dyskinesia in haloperidol-induced rat model

    S. -, V. Parcha (Dehardun, India)

    Objective: This investigation evaluates the effect of CA in orofacial dyskinesia in haloperidol-induced rat male model Background: Orofacial dyskinesias are involuntary repetitive movements of the…
  • 2022 International Congress

    Neurodegeneration and neuroinflammation for biomarker development in MSA

    S. Katzdobler, F. Eckenweber, G. Nübling, L. Vogler, C. Palleis, S. Lindner, U. Fietzek, B. Nuscher, A. Mueller, N. Koglin, A. Stephens, C. Haass, M. Brendel, J. Levin (Munich, Germany)

    Objective: To investigate the diagnostic and prognostic value of fluid-based and PET imaging biomarkers related to neurodegeneration and neuroinflammation in Multiple System Atrophy (MSA). Background:…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 25
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley